Atlas FSS LSJ
Awarded Limited / Sole Source Justification Posted
- Solicitation number
- 75F40120A00033
- Agency
-
FDA Office of Acquisition and Grant Services
Food and Drug Administration, Department of Health and Human Services
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75F40120A00033
- NAICS code
- Not on record
- PSC
- D308 It And Telecom- Programming
Notice details come from SAM.gov. Updated .
About this opportunity
The U.S. Food and Drug Administration's Office of Acquisition and Grant Services published a Limited Source Justification Notice on September 23, 2020 to award a blanket purchase agreement on a non-competitive basis to Deloitte Consulting, LLP for IT support services for the FDA's Applicant Tracking and Lifecycle Analysis Solution (ATLAS) system. The justification cites that under the terms of the FDA's end user licensing agreement with Deloitte, no other contractor can modify, upgrade, or enhance ATLAS due to restricted rights, making continued ATLAS support only available from Deloitte in accordance with FAR 8.405-6. The FDA seeks to award a BPA valued at an estimated $68 million over five years to Deloitte Consulting to provide follow-on support for enhancing, deploying, and maintaining ATLAS across the FDA by January 2021.
Notice text
IT support services for Applicant Tracking and Lifecycle Analysis Solution (ATLAS)
Awarded contract 75F40120A00033 to unknown vendor for unknown amount on 2020-09-10.
Files
| File | Type | Posted |
|---|---|---|
| JA OTS Limited Source Justification_ATLAS.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity